Articles from SEQSTER PDM Inc.

SEQSTER PDM Inc. (“SEQSTER”), the leading healthcare technology company powering the connection, collection, and orchestration layer of patient health data, today announced a strategic partnership with Astute, Inc. (“Astute”), a provider of secure infrastructure for hospitals, clinics, and home-based care, to help healthcare organizations more easily access patient data across clinical settings.

SEQSTER PDM Inc. ("SEQSTER"), the leading healthcare technology company, today announced that CEO and Co-Founder Ardy Arianpour has been named to the prestigious 2024 PharmaVoice 100, marking the second consecutive year he has received this recognition for his inspirational leadership and groundbreaking work in life sciences.

SEQSTER PDM Inc. (“SEQSTER”), the leading patient-centric healthcare technology company, and PatientsLikeMe (PLM), the leading integrated patient engagement, activation and health tracking platform, announce a strategic partnership to leverage SEQSTER’s Operating System and PLM’s patient trusted health communities to accelerate clinical research, enhance long-term patient engagement, and optimize clinical trial recruitment.

SEQSTER PDM Inc. ("SEQSTER"), the leading patient-centric healthcare technology company, announces at the Alzheimer's Association International Conference 2024 in Philadelphia, Pennsylvania it will work with Boston University researchers led by Rhoda Au, PhD, Professor of Anatomy and Neurobiology at Boston University Chobanian & Avedisian School of Medicine, Diagnostics Accelerator (DxA)-funded investigator, and recipient of the Alzheimer’s Drug Discovery Foundation’s (ADDF) 2023 Melvin R. Goodes Prize for Excellence in Alzheimer's Drug Development. The project, funded by the Goodes Prize, will leverage SEQSTER’s 1-Click Records to collect health information, providing the longitudinal data needed for Dr. Au and her team to begin developing an early-stage clinical screening tool for Alzheimer’s.

SEQSTER PDM Inc. (“SEQSTER”), the leading patient-centric healthcare technology company, and Antidote Technologies (“Antidote”), a digital health company that focuses on patient engagement to accelerate recruitment for clinical trials, today announced a partnership to enhance patient identification, improving trial timelines and enrollment outcomes for Pharma and Life Science companies with their fully integrated end-to-end solution.

SEQSTER PDM Inc. (“SEQSTER”), the leading patient-centric healthcare technology company, announced today a strategic partnership with Thread, a leading decentralized research and eCOA provider, to accelerate access to real-world data for patients, researchers and life science enterprises.

SEQSTER PDM Inc. (“SEQSTER”), the leading patient-centric healthcare technology company, has been selected by the Multiple Sclerosis Association of America (MSAA) for its patient-centricity, 1-Click Records™ and cutting-edge longitudinal health record. SEQSTER unifies people living with multiple sclerosis (MS), researchers, and care centers nationwide.

SEQSTER PDM Inc. (“SEQSTER”), the leading patient-centric healthcare technology company, announces the launch of the Admin Portal for Healthcare and Life Science stakeholders, a powerful tool designed to streamline the data collection lifecycle and expedite clinical trials.